A new study that included data from more than 53,000 patients with multiple sclerosis (MS) concluded that people with MS are nearly twice as likely to experience seizures compared to people without MS. The research, led by Valeria Pozzilli, Campus Bio-Medico University, Rome, Italy, was published in the Journal of Neurology, Neurosurgery & Psychiatry in…
Study: MS Patients at Nearly Double the Risk for Seizures
Study: Black Patients with MS Had Most Difficulty with Walking
New research suggests reconsidering rehabilitation needs for some patients.
A new study says Black patients with multiple sclerosis (MS) demonstrated more difficulty in walking compared to white counterparts with MS — and those increased difficulties were unrelated to social determinants of health (SDOH). The research — Walking and physical performance in black and white adults with multiple sclerosis controlling for social determinants of health…
Research: Gold Nanocrystal Trials Improved MS, Parkinson’s Symptoms
Findings suggest the treatments could also help patients with other neurodegenerative conditions.
Two clinical trials of gold nanocrystals at University of Texas Southwestern Medical Center resulted in “significantly reversed deficits of metabolites linked to energy activity in the brain and resulted in functional improvements” in patients with multiple sclerosis (MS) and Parkinson’s disease, the medical center said in a Feb. 13 news announcement. While these trials focused…
FDA Clears AI-Powered Brain MRI Software
Pixyl.Neuro has been used to detect and follow the progression of multiple sclerosis.
The U.S. Food & Drug Administration (FDA) has given 510(k) clearance to Pixyl.Neuro, brain MRI analysis software that’s powered by artificial intelligence (AI). In a Nov. 20 news announcement, Pixyl, a French medtech company specializing in AI-powered MRI solutions to improve patient care, said Pixyl.Neuro “automatically analyzes brain MRI images to support rapid detection, early…
Study: Low-Fat Diet Reduces Fatigue in MS Participants
The pilot clinical trial included lean animal-based proteins.
A new clinical trial found that people living with multiple sclerosis (MS) reported less fatigue while following a low-fat diet. The study was published in the Multiple Sclerosis Journal, November 2023 (volume 29, issue 13). Thirty-nine people living with MS participated in the 16-week randomized controlled trial: 20 in the active group and 19 in…